Dupont Jakob Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
14
Insider Sells Sum
$1.2M

Insider Activity of Dupont Jakob

According to the SEC Form 4 filings, Dupont Jakob, being in a position of

  1. director at Pyxis Oncology, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 35000 shares for $107,100,
    over all time since 2026-06-30, has bought 0 shares, and sold 35000 shares for $107,100.

Biography of Dupont Jakob

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $107,1001100

Comparison of Insiders on Amount of Buys and Sells

2026-06-30SalePyxis Oncology, Inc.
PYXS
director
35,000
0.0562%
$3.06$107,100-4.82%
2023-03-02SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
5,074
0.005%
$3.63$18,403-56.42%
2022-11-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
4,342
0.0041%
$4.49$19,497-51.86%
2022-08-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
4,124
0.0041%
$5.03$20,760-30.97%
2022-05-17SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
3,873
0.0036%
$5.32$20,597-27.55%
2022-03-01SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
2,221
0.0021%
$9.86$21,890-53.97%
2022-02-10SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
5,000
0.0053%
$16.00$80,000-67.95%
2022-01-03SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
5,000
0.0047%
$16.01$80,050-69.98%
2021-12-01SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
5,000
0.0053%
$17.94$89,689-66.71%
2021-11-16SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
2,199
0.0022%
$17.12$37,640-60.79%
2021-11-02SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
5,000
0.0049%
$16.41$82,050-57.55%
2021-08-17SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
2,152
0.0023%
$12.53$26,969+4.18%
2021-05-18SaleAtara Biotherapeutics, Inc.
ATRA
EVP, Head of R&D
5,184
0.0056%
$14.55$75,427+0.55%
2019-12-30SaleGossamer Bio, Inc.
GOSS
Chief Medical Officer
80,000
0.0714%
$7.50$600,004-17.39%
2019-12-27SaleGossamer Bio, Inc.
GOSS
Chief Medical Officer
3,988
0.0037%
$7.91$31,534-18.54%
Total: 15
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.